Literature DB >> 31624119

White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure.

S L Merhar1,2, N A Parikh3,2, A Braimah4, B B Poindexter3,2, J Tkach5, B Kline-Fath5.   

Abstract

Previous studies have not found structural injury or brain malformations in infants and children with prenatal opioid exposure. As part of an ongoing study evaluating neuroimaging in infants with prenatal opioid exposure, we reviewed structural brain MR imaging in 20 term infants with prenatal opioid exposure and 20 term controls at 4-8 weeks of age. We found that 8 of the 20 opioid-exposed infants had punctate white matter lesions or white matter signal abnormality on structural MR imaging, and 2 of the opioid-exposed infants had a septopreoptic fusion anomaly. No controls had white matter injury or structural malformations. Our findings underscore the importance of clinical neurodevelopmental follow-up and the need for more comprehensive imaging and long-term outcomes research following prenatal opioid exposure.
© 2019 by American Journal of Neuroradiology.

Entities:  

Year:  2019        PMID: 31624119      PMCID: PMC6911627          DOI: 10.3174/ajnr.A6282

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Neurodevelopmental outcomes in preterm infants: comparison of infants with and without diffuse excessive high signal intensity on MR images at near-term-equivalent age.

Authors:  Tae Yeon Jeon; Ji Hye Kim; So-Young Yoo; Hong Eo; Jeong-Yi Kwon; Jeehun Lee; Munhyang Lee; Yun Sil Chang; Won Soon Park
Journal:  Radiology       Date:  2012-03-08       Impact factor: 11.105

2.  Punctate white-matter lesions in the full-term newborn: Underlying aetiology and outcome.

Authors:  Michael Hayman; Gerda van Wezel-Meijler; Henrica van Straaten; Eva Brilstra; Floris Groenendaal; Linda S de Vries
Journal:  Eur J Paediatr Neurol       Date:  2019-01-26       Impact factor: 3.140

3.  Perinatal opioids reduce striatal nerve growth factor content in rat striatum.

Authors:  V W Wu; Q Mo; T Yabe; J P Schwartz; S E Robinson
Journal:  Eur J Pharmacol       Date:  2001-03-02       Impact factor: 4.432

4.  Septopreoptic holoprosencephaly: a mild subtype associated with midline craniofacial anomalies.

Authors:  J S Hahn; P D Barnes; N J Clegg; E E Stashinko
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

Review 5.  White matter injury in the preterm infant: pathology and mechanisms.

Authors:  Stephen A Back
Journal:  Acta Neuropathol       Date:  2017-05-22       Impact factor: 17.088

6.  Volumetric cerebral characteristics of children exposed to opiates and other substances in utero.

Authors:  K B Walhovd; V Moe; K Slinning; P Due-Tønnessen; A Bjørnerud; A M Dale; A van der Kouwe; B T Quinn; B Kosofsky; D Greve; B Fischl
Journal:  Neuroimage       Date:  2007-04-25       Impact factor: 6.556

7.  Do maternal opioids reduce neonatal regional brain volumes? A pilot study.

Authors:  Q Yuan; M Rubic; J Seah; C Rae; I M R Wright; K Kaltenbach; J M Feller; M E Abdel-Latif; C Chu; J L Oei
Journal:  J Perinatol       Date:  2014-06-19       Impact factor: 2.521

8.  Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care.

Authors:  Rachel L Epstein; Vishakha Sabharwal; Elisha M Wachman; Kelley A Saia; Claudia Vellozzi; Susan Hariri; Benjamin P Linas
Journal:  J Pediatr       Date:  2018-08-28       Impact factor: 6.314

9.  Prenatal methadone exposure is associated with altered neonatal brain development.

Authors:  Victoria J Monnelly; Devasuda Anblagan; Alan Quigley; Manuel Blesa Cabez; E Sarah Cooper; Helen Mactier; Scott I Semple; Mark E Bastin; James P Boardman
Journal:  Neuroimage Clin       Date:  2017-12-24       Impact factor: 4.881

10.  Maternal smoking during pregnancy and fetal organ growth: a magnetic resonance imaging study.

Authors:  Devasuda Anblagan; Nia W Jones; Carolyn Costigan; Alexander J J Parker; Kirsty Allcock; Rosanne Aleong; Lucy H Coyne; Ruta Deshpande; Nick Raine-Fenning; George Bugg; Neil Roberts; Zdenka Pausova; Tomáš Paus; Penny A Gowland
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  13 in total

1.  Early white matter tract changes in neonates with prenatal opioid exposure: a pilot study.

Authors:  Pooja Sikka; Neel Madan; Elizabeth Yen
Journal:  J Perinatol       Date:  2022-06-18       Impact factor: 3.225

2.  Outcomes of Babies with Opioid Exposure (OBOE): protocol of a prospective longitudinal cohort study.

Authors:  Carla M Bann; Jamie E Newman; Brenda Poindexter; Katherine Okoniewski; Sara DeMauro; Scott A Lorch; Deanne Wilson-Costello; Namasivayam Ambalavanan; Myriam Peralta-Carcelen; Catherine Limperopoulos; Kushal Kapse; Jonathan M Davis; Michele Walsh; Stephanie Merhar
Journal:  Pediatr Res       Date:  2022-08-30       Impact factor: 3.953

3.  Thalamocortical functional connectivity in infants with prenatal opioid exposure correlates with severity of neonatal opioid withdrawal syndrome.

Authors:  Rupa Radhakrishnan; Ramana V Vishnubhotla; Zoe Guckien; Yi Zhao; Gregory M Sokol; David M Haas; Senthilkumar Sadhasivam
Journal:  Neuroradiology       Date:  2022-04-12       Impact factor: 2.995

4.  Perinatal methadone exposure attenuates myelination and induces oligodendrocyte apoptosis in neonatal rat brain.

Authors:  Jennifer M Gibson; Tianci Chu; Wenxin Zeng; Ashley C Wethall; Maiying Kong; Nicholas Mellen; Lori A Devlin Phinney; Jun Cai
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

5.  Pilot study of fetal brain development and morphometry in prenatal opioid exposure and smoking on fetal MRI.

Authors:  Rupa Radhakrishnan; Brandon P Brown; David M Haas; Yong Zang; Christina Sparks; Senthilkumar Sadhasivam
Journal:  J Neuroradiol       Date:  2021-01-05       Impact factor: 3.447

Review 6.  Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research.

Authors:  Rupa Radhakrishnan; Gregory Grecco; Kellen Stolze; Brady Atwood; Samuel G Jennings; Izlin Z Lien; Andrew J Saykin; Senthilkumar Sadhasivam
Journal:  J Neuroradiol       Date:  2020-10-13       Impact factor: 3.447

Review 7.  Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination.

Authors:  Brandon Velasco; Esraa Mohamed; Carmen Sato-Bigbee
Journal:  Neurotoxicol Teratol       Date:  2021-06-12       Impact factor: 4.071

8.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

9.  A Holistic Systems Approach to Characterize the Impact of Pre- and Post-natal Oxycodone Exposure on Neurodevelopment and Behavior.

Authors:  Katherine E Odegaard; Victoria L Schaal; Alexander R Clark; Sneh Koul; Jagadesan Sankarasubramanian; Zhiqiu Xia; Melissa Mellon; Mariano Uberti; Yutong Liu; Andrew Stothert; Matthew Van Hook; Hanjun Wang; Chittibabu Guda; Steven J Lisco; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Front Cell Dev Biol       Date:  2021-01-07

10.  Use of Phenobarbital to Treat Neonatal Abstinence Syndrome From Exposure to Single vs. Multiple Substances.

Authors:  Alla Kushnir; Cynthia Garretson; Maheswari Mariappan; Gary Stahl
Journal:  Front Pediatr       Date:  2022-01-31       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.